+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase Not Applicable
Age: 3Days - 14Days
All Genders
Healthy Volunteers
ID06361719

Trial to Evaluate the Effects of Two Human Milk Oligosaccharides Added to Starter Infant Formula in Healthy Chinese Newborns

Led by Société des Produits Nestlé (SPN) · Updated on 2025-11-28

262

Participants Needed

1

Research Sites

30 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying healthy male and female term infants in China to evaluate how two human milk oligosaccharides HMOs might positively affect gut bacteria, gut development, gut barrier strength, immune responses, and other growth outcomes. The study is a randomized, controlled, double-blind trial that includes two groups of formula-fed infants and a non-randomized breastfed reference group. Infants in the two formula-fed groups will receive starter infant formulas either supplemented with the two HMOs or without them. Both formula groups will consume their assigned starter formula freely up to 6 months of age, after which they will switch to a standard follow-up formula until 12 months. The breastfed group will continue receiving breast milk as a reference for comparison. During the study, researchers will collect fecal samples to analyze gut bacteria, metabolism, immune health markers, gut barrier function, and inflammation at various points up to 12 months of age. They will also assess stool patterns, gastrointestinal symptoms, immune competence, sleep, quality of life, growth, physical exams, illnesses, and medication use. This comprehensive monitoring will help understand the effects of HMOs on infant development over the first year of life.

CONDITIONS

Brief Title

Efficacy of Two HMOs in Chinese Infants

Research Team

Q

Qiaoji Li

J

Joyce Li

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here